The NSW Pharmacy Trial is a research study that allowed appropriately trained community pharmacists to provide services for:
These services were delivered under trial conditions to assess patient safety and collect robust data.
The University of Newcastle led the trial in association with the University of Technology Sydney, University of New England, Charles Sturt University, The George Institute for Global Health and the Hunter Medical Research Institute, peak bodies and other professional organisations.
An evaluation of the UTI and OCP phases of the NSW Pharmacy Trial will be provided to NSW Health in 2025, while evaluation of the dermatology phase will be provided in 2026, along with a detailed evaluation of all aspects of the trial. These evaluations will be used to inform future service delivery models.
